UCLA Hematology Oncology- Laguna Hills — Laguna Hills, California

UCLA Hematology Oncology- Laguna Hills is a clinical research site located in Laguna Hills, California, United States 92653.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

UCLA Hematology Oncology- Laguna Hills has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer, Prostate Cancer.

Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Laguna Hills

Browse all research sites in California · View every site in Laguna Hills

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Hematology Oncology- Laguna Hills?

UCLA Hematology Oncology- Laguna Hills has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Hematology Oncology- Laguna Hills conducted?

UCLA Hematology Oncology- Laguna Hills has 4 clinical trials on record, with 2 currently active. Their work covers Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer, Prostate Cancer.

Is UCLA Hematology Oncology- Laguna Hills accredited by Crixeo Clinical Trials?

UCLA Hematology Oncology- Laguna Hills has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Hematology Oncology- Laguna Hills?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.